ADVERTISEMENT

Gland Pharma Q1 Results Review - Lower Milestone Income, ROW Sales Hurt Earnings: Motilal Oswal

The favorable regulatory developments at the industry level would enable better business prospects for the company as well, the brokerage reiterates Buy.

<div class="paragraphs"><p>Injectables manufactured by Gland Pharma Ltd. (Source: Company website).</p></div>
Injectables manufactured by Gland Pharma Ltd. (Source: Company website).
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit